nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—AHR—stomach cancer	0.694	1	CbGaD
Nimodipine—CACNB3—digestive system—stomach cancer	0.00152	0.057	CbGeAlD
Nimodipine—AHR—smooth muscle tissue—stomach cancer	0.00142	0.0535	CbGeAlD
Nimodipine—AHR—pancreas—stomach cancer	0.00132	0.0494	CbGeAlD
Nimodipine—AHR—digestive system—stomach cancer	0.00112	0.0422	CbGeAlD
Nimodipine—NR3C2—hematopoietic system—stomach cancer	0.00108	0.0404	CbGeAlD
Nimodipine—CACNA1D—pancreas—stomach cancer	0.00104	0.0392	CbGeAlD
Nimodipine—CACNA1C—smooth muscle tissue—stomach cancer	0.00104	0.0391	CbGeAlD
Nimodipine—AHR—bone marrow—stomach cancer	0.00104	0.0389	CbGeAlD
Nimodipine—CACNB2—digestive system—stomach cancer	0.00102	0.0383	CbGeAlD
Nimodipine—NR3C2—smooth muscle tissue—stomach cancer	0.000948	0.0356	CbGeAlD
Nimodipine—AHR—endocrine gland—stomach cancer	0.000929	0.0349	CbGeAlD
Nimodipine—CACNB1—lymph node—stomach cancer	0.000904	0.034	CbGeAlD
Nimodipine—CACNB3—lymph node—stomach cancer	0.000867	0.0326	CbGeAlD
Nimodipine—Amlodipine—CA1—stomach cancer	0.000852	0.376	CrCbGaD
Nimodipine—AHR—liver—stomach cancer	0.000837	0.0315	CbGeAlD
Nimodipine—CACNA1C—digestive system—stomach cancer	0.000823	0.0309	CbGeAlD
Nimodipine—CACNB2—liver—stomach cancer	0.000759	0.0285	CbGeAlD
Nimodipine—NR3C2—digestive system—stomach cancer	0.000749	0.0281	CbGeAlD
Nimodipine—Dyspnoea—Mitomycin—stomach cancer	0.000738	0.007	CcSEcCtD
Nimodipine—CACNA1D—endocrine gland—stomach cancer	0.000736	0.0277	CbGeAlD
Nimodipine—Hyponatraemia—Irinotecan—stomach cancer	0.000735	0.00697	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Irinotecan—stomach cancer	0.000732	0.00694	CcSEcCtD
Nimodipine—Diarrhoea—Floxuridine—stomach cancer	0.000722	0.00685	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Fluorouracil—stomach cancer	0.000701	0.00664	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Docetaxel—stomach cancer	0.000697	0.00661	CcSEcCtD
Nimodipine—CACNA1C—endocrine gland—stomach cancer	0.00068	0.0255	CbGeAlD
Nimodipine—Phosphatase alkaline increased—Capecitabine—stomach cancer	0.000675	0.0064	CcSEcCtD
Nimodipine—Vomiting—Floxuridine—stomach cancer	0.000671	0.00636	CcSEcCtD
Nimodipine—Rash—Floxuridine—stomach cancer	0.000665	0.00631	CcSEcCtD
Nimodipine—Dermatitis—Floxuridine—stomach cancer	0.000665	0.0063	CcSEcCtD
Nimodipine—Ileus—Epirubicin—stomach cancer	0.000664	0.0063	CcSEcCtD
Nimodipine—CACNA1D—liver—stomach cancer	0.000664	0.0249	CbGeAlD
Nimodipine—Fluid retention—Docetaxel—stomach cancer	0.000661	0.00627	CcSEcCtD
Nimodipine—Headache—Floxuridine—stomach cancer	0.000661	0.00627	CcSEcCtD
Nimodipine—Cramp muscle—Irinotecan—stomach cancer	0.000659	0.00625	CcSEcCtD
Nimodipine—AHR—lymph node—stomach cancer	0.000642	0.0241	CbGeAlD
Nimodipine—Fluid retention—Capecitabine—stomach cancer	0.00064	0.00607	CcSEcCtD
Nimodipine—Nausea—Floxuridine—stomach cancer	0.000627	0.00594	CcSEcCtD
Nimodipine—Lightheadedness—Docetaxel—stomach cancer	0.000623	0.00591	CcSEcCtD
Nimodipine—NR3C2—endocrine gland—stomach cancer	0.000619	0.0232	CbGeAlD
Nimodipine—Sweating increased—Irinotecan—stomach cancer	0.000616	0.00584	CcSEcCtD
Nimodipine—Ileus—Doxorubicin—stomach cancer	0.000614	0.00583	CcSEcCtD
Nimodipine—Phlebitis—Docetaxel—stomach cancer	0.000587	0.00557	CcSEcCtD
Nimodipine—CACNB2—lymph node—stomach cancer	0.000582	0.0219	CbGeAlD
Nimodipine—CYP3A5—hematopoietic system—stomach cancer	0.000582	0.0219	CbGeAlD
Nimodipine—Blood alkaline phosphatase increased—Docetaxel—stomach cancer	0.000581	0.00551	CcSEcCtD
Nimodipine—Phlebitis—Capecitabine—stomach cancer	0.000568	0.00539	CcSEcCtD
Nimodipine—Diarrhoea—Mitomycin—stomach cancer	0.000567	0.00537	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Capecitabine—stomach cancer	0.000563	0.00534	CcSEcCtD
Nimodipine—NR3C2—liver—stomach cancer	0.000558	0.021	CbGeAlD
Nimodipine—Cardiac failure congestive—Docetaxel—stomach cancer	0.000558	0.00529	CcSEcCtD
Nimodipine—Jaundice—Irinotecan—stomach cancer	0.00055	0.00521	CcSEcCtD
Nimodipine—Dizziness—Mitomycin—stomach cancer	0.000548	0.00519	CcSEcCtD
Nimodipine—Nilvadipine—CYP2A6—stomach cancer	0.000537	0.237	CrCbGaD
Nimodipine—Vomiting—Mitomycin—stomach cancer	0.000526	0.00499	CcSEcCtD
Nimodipine—Rash—Mitomycin—stomach cancer	0.000522	0.00495	CcSEcCtD
Nimodipine—Dermatitis—Mitomycin—stomach cancer	0.000522	0.00495	CcSEcCtD
Nimodipine—Headache—Mitomycin—stomach cancer	0.000519	0.00492	CcSEcCtD
Nimodipine—Bradycardia—Irinotecan—stomach cancer	0.000515	0.00489	CcSEcCtD
Nimodipine—CACNA1D—lymph node—stomach cancer	0.000509	0.0191	CbGeAlD
Nimodipine—Hyponatraemia—Docetaxel—stomach cancer	0.000508	0.00482	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Docetaxel—stomach cancer	0.000506	0.0048	CcSEcCtD
Nimodipine—Nausea—Mitomycin—stomach cancer	0.000492	0.00466	CcSEcCtD
Nimodipine—Hyponatraemia—Capecitabine—stomach cancer	0.000492	0.00466	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Capecitabine—stomach cancer	0.00049	0.00464	CcSEcCtD
Nimodipine—CYP3A5—pancreas—stomach cancer	0.000474	0.0178	CbGeAlD
Nimodipine—Phosphatase alkaline increased—Epirubicin—stomach cancer	0.00047	0.00446	CcSEcCtD
Nimodipine—CACNA1C—lymph node—stomach cancer	0.00047	0.0177	CbGeAlD
Nimodipine—Cardiac disorder—Irinotecan—stomach cancer	0.00047	0.00445	CcSEcCtD
Nimodipine—Flushing—Irinotecan—stomach cancer	0.00047	0.00445	CcSEcCtD
Nimodipine—Liver function test abnormal—Docetaxel—stomach cancer	0.000467	0.00443	CcSEcCtD
Nimodipine—Amlodipine—CYP2A6—stomach cancer	0.000462	0.204	CrCbGaD
Nimodipine—Angiopathy—Irinotecan—stomach cancer	0.000459	0.00435	CcSEcCtD
Nimodipine—Immune system disorder—Irinotecan—stomach cancer	0.000457	0.00434	CcSEcCtD
Nimodipine—Cramp muscle—Docetaxel—stomach cancer	0.000455	0.00432	CcSEcCtD
Nimodipine—Liver function test abnormal—Capecitabine—stomach cancer	0.000452	0.00429	CcSEcCtD
Nimodipine—Fluid retention—Epirubicin—stomach cancer	0.000446	0.00423	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Docetaxel—stomach cancer	0.000446	0.00423	CcSEcCtD
Nimodipine—CYP3A4—hematopoietic system—stomach cancer	0.000437	0.0164	CbGeAlD
Nimodipine—Phosphatase alkaline increased—Doxorubicin—stomach cancer	0.000435	0.00412	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Capecitabine—stomach cancer	0.000432	0.0041	CcSEcCtD
Nimodipine—NR3C2—lymph node—stomach cancer	0.000428	0.0161	CbGeAlD
Nimodipine—Muscle spasms—Irinotecan—stomach cancer	0.000424	0.00402	CcSEcCtD
Nimodipine—Nifedipine—CYP2A6—stomach cancer	0.000414	0.183	CrCbGaD
Nimodipine—Fluid retention—Doxorubicin—stomach cancer	0.000413	0.00391	CcSEcCtD
Nimodipine—Sweating increased—Capecitabine—stomach cancer	0.000412	0.00391	CcSEcCtD
Nimodipine—Anaemia—Irinotecan—stomach cancer	0.000407	0.00386	CcSEcCtD
Nimodipine—CYP3A5—digestive system—stomach cancer	0.000405	0.0152	CbGeAlD
Nimodipine—Phlebitis—Epirubicin—stomach cancer	0.000396	0.00375	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Epirubicin—stomach cancer	0.000392	0.00372	CcSEcCtD
Nimodipine—Anaemia—Fluorouracil—stomach cancer	0.00039	0.0037	CcSEcCtD
Nimodipine—Hypertension—Irinotecan—stomach cancer	0.00038	0.00361	CcSEcCtD
Nimodipine—Jaundice—Docetaxel—stomach cancer	0.00038	0.0036	CcSEcCtD
Nimodipine—Depression—Capecitabine—stomach cancer	0.000376	0.00357	CcSEcCtD
Nimodipine—Cardiac failure congestive—Epirubicin—stomach cancer	0.000376	0.00357	CcSEcCtD
Nimodipine—Hepatobiliary disease—Docetaxel—stomach cancer	0.000369	0.0035	CcSEcCtD
Nimodipine—Jaundice—Capecitabine—stomach cancer	0.000368	0.00349	CcSEcCtD
Nimodipine—Phlebitis—Doxorubicin—stomach cancer	0.000366	0.00347	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Doxorubicin—stomach cancer	0.000363	0.00344	CcSEcCtD
Nimodipine—Oedema—Irinotecan—stomach cancer	0.00036	0.00341	CcSEcCtD
Nimodipine—Myalgia—Fluorouracil—stomach cancer	0.000359	0.00341	CcSEcCtD
Nimodipine—Hepatobiliary disease—Capecitabine—stomach cancer	0.000357	0.00338	CcSEcCtD
Nimodipine—Nervous system disorder—Irinotecan—stomach cancer	0.000353	0.00334	CcSEcCtD
Nimodipine—Thrombocytopenia—Irinotecan—stomach cancer	0.000352	0.00334	CcSEcCtD
Nimodipine—Hepatitis—Docetaxel—stomach cancer	0.00035	0.00332	CcSEcCtD
Nimodipine—Cardiac failure congestive—Doxorubicin—stomach cancer	0.000348	0.0033	CcSEcCtD
Nimodipine—Hyperhidrosis—Irinotecan—stomach cancer	0.000348	0.0033	CcSEcCtD
Nimodipine—Bradycardia—Capecitabine—stomach cancer	0.000345	0.00327	CcSEcCtD
Nimodipine—Oedema—Fluorouracil—stomach cancer	0.000344	0.00327	CcSEcCtD
Nimodipine—Hyponatraemia—Epirubicin—stomach cancer	0.000343	0.00325	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Epirubicin—stomach cancer	0.000341	0.00323	CcSEcCtD
Nimodipine—Hepatitis—Capecitabine—stomach cancer	0.000339	0.00321	CcSEcCtD
Nimodipine—Nervous system disorder—Fluorouracil—stomach cancer	0.000338	0.0032	CcSEcCtD
Nimodipine—Thrombocytopenia—Fluorouracil—stomach cancer	0.000337	0.0032	CcSEcCtD
Nimodipine—Liver function test abnormal—Methotrexate—stomach cancer	0.000337	0.00319	CcSEcCtD
Nimodipine—Tachycardia—Fluorouracil—stomach cancer	0.000336	0.00319	CcSEcCtD
Nimodipine—Hypotension—Irinotecan—stomach cancer	0.000336	0.00319	CcSEcCtD
Nimodipine—CYP3A5—endocrine gland—stomach cancer	0.000334	0.0126	CbGeAlD
Nimodipine—Cardiac disorder—Docetaxel—stomach cancer	0.000325	0.00308	CcSEcCtD
Nimodipine—Flushing—Docetaxel—stomach cancer	0.000325	0.00308	CcSEcCtD
Nimodipine—Hypotension—Fluorouracil—stomach cancer	0.000322	0.00305	CcSEcCtD
Nimodipine—Dyspnoea—Irinotecan—stomach cancer	0.000321	0.00304	CcSEcCtD
Nimodipine—Angiopathy—Docetaxel—stomach cancer	0.000317	0.00301	CcSEcCtD
Nimodipine—Hyponatraemia—Doxorubicin—stomach cancer	0.000317	0.00301	CcSEcCtD
Nimodipine—Immune system disorder—Docetaxel—stomach cancer	0.000316	0.003	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Doxorubicin—stomach cancer	0.000316	0.00299	CcSEcCtD
Nimodipine—Liver function test abnormal—Epirubicin—stomach cancer	0.000315	0.00299	CcSEcCtD
Nimodipine—Cardiac disorder—Capecitabine—stomach cancer	0.000314	0.00298	CcSEcCtD
Nimodipine—Flushing—Capecitabine—stomach cancer	0.000314	0.00298	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000314	0.00298	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00031	0.00294	CcSEcCtD
Nimodipine—Angiopathy—Capecitabine—stomach cancer	0.000307	0.00291	CcSEcCtD
Nimodipine—Dyspnoea—Fluorouracil—stomach cancer	0.000307	0.00291	CcSEcCtD
Nimodipine—Immune system disorder—Capecitabine—stomach cancer	0.000306	0.0029	CcSEcCtD
Nimodipine—CYP3A4—digestive system—stomach cancer	0.000304	0.0114	CbGeAlD
Nimodipine—CYP3A5—liver—stomach cancer	0.000301	0.0113	CbGeAlD
Nimodipine—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.000301	0.00285	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000297	0.00282	CcSEcCtD
Nimodipine—Muscle spasms—Docetaxel—stomach cancer	0.000293	0.00278	CcSEcCtD
Nimodipine—Liver function test abnormal—Doxorubicin—stomach cancer	0.000291	0.00276	CcSEcCtD
Nimodipine—Muscle spasms—Capecitabine—stomach cancer	0.000284	0.00269	CcSEcCtD
Nimodipine—Anaemia—Docetaxel—stomach cancer	0.000282	0.00267	CcSEcCtD
Nimodipine—Depression—Methotrexate—stomach cancer	0.00028	0.00266	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000278	0.00264	CcSEcCtD
Nimodipine—Anaemia—Capecitabine—stomach cancer	0.000273	0.00258	CcSEcCtD
Nimodipine—Palpitations—Docetaxel—stomach cancer	0.000269	0.00255	CcSEcCtD
Nimodipine—Hepatobiliary disease—Methotrexate—stomach cancer	0.000266	0.00252	CcSEcCtD
Nimodipine—Hypersensitivity—Irinotecan—stomach cancer	0.000265	0.00251	CcSEcCtD
Nimodipine—Hypertension—Docetaxel—stomach cancer	0.000263	0.00249	CcSEcCtD
Nimodipine—Palpitations—Capecitabine—stomach cancer	0.000261	0.00247	CcSEcCtD
Nimodipine—Myalgia—Docetaxel—stomach cancer	0.000259	0.00246	CcSEcCtD
Nimodipine—Jaundice—Epirubicin—stomach cancer	0.000256	0.00243	CcSEcCtD
Nimodipine—Hypertension—Capecitabine—stomach cancer	0.000255	0.00241	CcSEcCtD
Nimodipine—Hypersensitivity—Fluorouracil—stomach cancer	0.000254	0.00241	CcSEcCtD
Nimodipine—Hepatitis—Methotrexate—stomach cancer	0.000252	0.00239	CcSEcCtD
Nimodipine—Myalgia—Capecitabine—stomach cancer	0.000251	0.00238	CcSEcCtD
Nimodipine—CYP3A4—endocrine gland—stomach cancer	0.000251	0.00943	CbGeAlD
Nimodipine—Hepatobiliary disease—Epirubicin—stomach cancer	0.000249	0.00236	CcSEcCtD
Nimodipine—Oedema—Docetaxel—stomach cancer	0.000249	0.00236	CcSEcCtD
Nimodipine—Diarrhoea—Irinotecan—stomach cancer	0.000246	0.00233	CcSEcCtD
Nimodipine—Nervous system disorder—Docetaxel—stomach cancer	0.000244	0.00231	CcSEcCtD
Nimodipine—Pruritus—Fluorouracil—stomach cancer	0.000244	0.00231	CcSEcCtD
Nimodipine—Thrombocytopenia—Docetaxel—stomach cancer	0.000243	0.00231	CcSEcCtD
Nimodipine—Tachycardia—Docetaxel—stomach cancer	0.000243	0.0023	CcSEcCtD
Nimodipine—Oedema—Capecitabine—stomach cancer	0.000241	0.00228	CcSEcCtD
Nimodipine—Bradycardia—Epirubicin—stomach cancer	0.00024	0.00228	CcSEcCtD
Nimodipine—Dizziness—Irinotecan—stomach cancer	0.000238	0.00225	CcSEcCtD
Nimodipine—Jaundice—Doxorubicin—stomach cancer	0.000237	0.00225	CcSEcCtD
Nimodipine—Nervous system disorder—Capecitabine—stomach cancer	0.000236	0.00224	CcSEcCtD
Nimodipine—Hepatitis—Epirubicin—stomach cancer	0.000236	0.00224	CcSEcCtD
Nimodipine—Diarrhoea—Fluorouracil—stomach cancer	0.000236	0.00223	CcSEcCtD
Nimodipine—Thrombocytopenia—Capecitabine—stomach cancer	0.000236	0.00223	CcSEcCtD
Nimodipine—Tachycardia—Capecitabine—stomach cancer	0.000235	0.00223	CcSEcCtD
Nimodipine—Cardiac disorder—Methotrexate—stomach cancer	0.000234	0.00222	CcSEcCtD
Nimodipine—Hyperhidrosis—Capecitabine—stomach cancer	0.000233	0.00221	CcSEcCtD
Nimodipine—Hypotension—Docetaxel—stomach cancer	0.000232	0.0022	CcSEcCtD
Nimodipine—Hepatobiliary disease—Doxorubicin—stomach cancer	0.00023	0.00218	CcSEcCtD
Nimodipine—Angiopathy—Methotrexate—stomach cancer	0.000229	0.00217	CcSEcCtD
Nimodipine—Vomiting—Irinotecan—stomach cancer	0.000229	0.00217	CcSEcCtD
Nimodipine—Immune system disorder—Methotrexate—stomach cancer	0.000228	0.00216	CcSEcCtD
Nimodipine—Dizziness—Fluorouracil—stomach cancer	0.000228	0.00216	CcSEcCtD
Nimodipine—Rash—Irinotecan—stomach cancer	0.000227	0.00215	CcSEcCtD
Nimodipine—Dermatitis—Irinotecan—stomach cancer	0.000227	0.00215	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000226	0.00215	CcSEcCtD
Nimodipine—CYP3A4—liver—stomach cancer	0.000226	0.0085	CbGeAlD
Nimodipine—Headache—Irinotecan—stomach cancer	0.000225	0.00214	CcSEcCtD
Nimodipine—Hypotension—Capecitabine—stomach cancer	0.000225	0.00213	CcSEcCtD
Nimodipine—Bradycardia—Doxorubicin—stomach cancer	0.000222	0.00211	CcSEcCtD
Nimodipine—Dyspnoea—Docetaxel—stomach cancer	0.000222	0.0021	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000219	0.00208	CcSEcCtD
Nimodipine—Flushing—Epirubicin—stomach cancer	0.000219	0.00208	CcSEcCtD
Nimodipine—Cardiac disorder—Epirubicin—stomach cancer	0.000219	0.00208	CcSEcCtD
Nimodipine—Vomiting—Fluorouracil—stomach cancer	0.000219	0.00208	CcSEcCtD
Nimodipine—Hepatitis—Doxorubicin—stomach cancer	0.000218	0.00207	CcSEcCtD
Nimodipine—Rash—Fluorouracil—stomach cancer	0.000217	0.00206	CcSEcCtD
Nimodipine—Dermatitis—Fluorouracil—stomach cancer	0.000217	0.00206	CcSEcCtD
Nimodipine—Headache—Fluorouracil—stomach cancer	0.000216	0.00205	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000215	0.00204	CcSEcCtD
Nimodipine—Dyspnoea—Capecitabine—stomach cancer	0.000215	0.00203	CcSEcCtD
Nimodipine—Angiopathy—Epirubicin—stomach cancer	0.000214	0.00203	CcSEcCtD
Nimodipine—Nausea—Irinotecan—stomach cancer	0.000214	0.00203	CcSEcCtD
Nimodipine—Immune system disorder—Epirubicin—stomach cancer	0.000213	0.00202	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000208	0.00197	CcSEcCtD
Nimodipine—Nausea—Fluorouracil—stomach cancer	0.000205	0.00194	CcSEcCtD
Nimodipine—Anaemia—Methotrexate—stomach cancer	0.000203	0.00192	CcSEcCtD
Nimodipine—Flushing—Doxorubicin—stomach cancer	0.000203	0.00192	CcSEcCtD
Nimodipine—Cardiac disorder—Doxorubicin—stomach cancer	0.000203	0.00192	CcSEcCtD
Nimodipine—Angiopathy—Doxorubicin—stomach cancer	0.000198	0.00188	CcSEcCtD
Nimodipine—Muscle spasms—Epirubicin—stomach cancer	0.000198	0.00187	CcSEcCtD
Nimodipine—Immune system disorder—Doxorubicin—stomach cancer	0.000197	0.00187	CcSEcCtD
Nimodipine—Anaemia—Epirubicin—stomach cancer	0.00019	0.0018	CcSEcCtD
Nimodipine—Myalgia—Methotrexate—stomach cancer	0.000187	0.00177	CcSEcCtD
Nimodipine—Hypersensitivity—Docetaxel—stomach cancer	0.000183	0.00174	CcSEcCtD
Nimodipine—Muscle spasms—Doxorubicin—stomach cancer	0.000183	0.00173	CcSEcCtD
Nimodipine—Palpitations—Epirubicin—stomach cancer	0.000182	0.00172	CcSEcCtD
Nimodipine—Hypertension—Epirubicin—stomach cancer	0.000177	0.00168	CcSEcCtD
Nimodipine—Hypersensitivity—Capecitabine—stomach cancer	0.000177	0.00168	CcSEcCtD
Nimodipine—Pruritus—Docetaxel—stomach cancer	0.000176	0.00167	CcSEcCtD
Nimodipine—Nervous system disorder—Methotrexate—stomach cancer	0.000176	0.00167	CcSEcCtD
Nimodipine—Anaemia—Doxorubicin—stomach cancer	0.000176	0.00167	CcSEcCtD
Nimodipine—Thrombocytopenia—Methotrexate—stomach cancer	0.000175	0.00166	CcSEcCtD
Nimodipine—Myalgia—Epirubicin—stomach cancer	0.000175	0.00166	CcSEcCtD
Nimodipine—Hyperhidrosis—Methotrexate—stomach cancer	0.000173	0.00164	CcSEcCtD
Nimodipine—Pruritus—Capecitabine—stomach cancer	0.00017	0.00161	CcSEcCtD
Nimodipine—Diarrhoea—Docetaxel—stomach cancer	0.00017	0.00161	CcSEcCtD
Nimodipine—Palpitations—Doxorubicin—stomach cancer	0.000168	0.00159	CcSEcCtD
Nimodipine—Oedema—Epirubicin—stomach cancer	0.000168	0.00159	CcSEcCtD
Nimodipine—Hypotension—Methotrexate—stomach cancer	0.000167	0.00159	CcSEcCtD
Nimodipine—Diarrhoea—Capecitabine—stomach cancer	0.000165	0.00156	CcSEcCtD
Nimodipine—Nervous system disorder—Epirubicin—stomach cancer	0.000164	0.00156	CcSEcCtD
Nimodipine—Dizziness—Docetaxel—stomach cancer	0.000164	0.00156	CcSEcCtD
Nimodipine—Thrombocytopenia—Epirubicin—stomach cancer	0.000164	0.00156	CcSEcCtD
Nimodipine—Hypertension—Doxorubicin—stomach cancer	0.000164	0.00156	CcSEcCtD
Nimodipine—Tachycardia—Epirubicin—stomach cancer	0.000164	0.00155	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000163	0.00155	CcSEcCtD
Nimodipine—Hyperhidrosis—Epirubicin—stomach cancer	0.000162	0.00154	CcSEcCtD
Nimodipine—Myalgia—Doxorubicin—stomach cancer	0.000162	0.00153	CcSEcCtD
Nimodipine—Dyspnoea—Methotrexate—stomach cancer	0.00016	0.00151	CcSEcCtD
Nimodipine—Dizziness—Capecitabine—stomach cancer	0.000159	0.00151	CcSEcCtD
Nimodipine—Vomiting—Docetaxel—stomach cancer	0.000158	0.0015	CcSEcCtD
Nimodipine—Rash—Docetaxel—stomach cancer	0.000157	0.00149	CcSEcCtD
Nimodipine—Hypotension—Epirubicin—stomach cancer	0.000157	0.00149	CcSEcCtD
Nimodipine—Dermatitis—Docetaxel—stomach cancer	0.000157	0.00148	CcSEcCtD
Nimodipine—Headache—Docetaxel—stomach cancer	0.000156	0.00148	CcSEcCtD
Nimodipine—Oedema—Doxorubicin—stomach cancer	0.000155	0.00147	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000155	0.00147	CcSEcCtD
Nimodipine—Vomiting—Capecitabine—stomach cancer	0.000153	0.00145	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000153	0.00145	CcSEcCtD
Nimodipine—Nervous system disorder—Doxorubicin—stomach cancer	0.000152	0.00144	CcSEcCtD
Nimodipine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000152	0.00144	CcSEcCtD
Nimodipine—Rash—Capecitabine—stomach cancer	0.000152	0.00144	CcSEcCtD
Nimodipine—Dermatitis—Capecitabine—stomach cancer	0.000152	0.00144	CcSEcCtD
Nimodipine—Tachycardia—Doxorubicin—stomach cancer	0.000151	0.00144	CcSEcCtD
Nimodipine—Headache—Capecitabine—stomach cancer	0.000151	0.00143	CcSEcCtD
Nimodipine—Hyperhidrosis—Doxorubicin—stomach cancer	0.00015	0.00142	CcSEcCtD
Nimodipine—Dyspnoea—Epirubicin—stomach cancer	0.000149	0.00142	CcSEcCtD
Nimodipine—Nausea—Docetaxel—stomach cancer	0.000148	0.0014	CcSEcCtD
Nimodipine—Hypotension—Doxorubicin—stomach cancer	0.000145	0.00137	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000145	0.00137	CcSEcCtD
Nimodipine—Nausea—Capecitabine—stomach cancer	0.000143	0.00136	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000141	0.00134	CcSEcCtD
Nimodipine—Dyspnoea—Doxorubicin—stomach cancer	0.000138	0.00131	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000134	0.00127	CcSEcCtD
Nimodipine—Hypersensitivity—Methotrexate—stomach cancer	0.000132	0.00125	CcSEcCtD
Nimodipine—Pruritus—Methotrexate—stomach cancer	0.000127	0.0012	CcSEcCtD
Nimodipine—Hypersensitivity—Epirubicin—stomach cancer	0.000124	0.00117	CcSEcCtD
Nimodipine—Diarrhoea—Methotrexate—stomach cancer	0.000123	0.00116	CcSEcCtD
Nimodipine—Pruritus—Epirubicin—stomach cancer	0.000119	0.00112	CcSEcCtD
Nimodipine—Dizziness—Methotrexate—stomach cancer	0.000118	0.00112	CcSEcCtD
Nimodipine—Diarrhoea—Epirubicin—stomach cancer	0.000115	0.00109	CcSEcCtD
Nimodipine—Hypersensitivity—Doxorubicin—stomach cancer	0.000114	0.00108	CcSEcCtD
Nimodipine—Vomiting—Methotrexate—stomach cancer	0.000114	0.00108	CcSEcCtD
Nimodipine—Rash—Methotrexate—stomach cancer	0.000113	0.00107	CcSEcCtD
Nimodipine—Dermatitis—Methotrexate—stomach cancer	0.000113	0.00107	CcSEcCtD
Nimodipine—Headache—Methotrexate—stomach cancer	0.000112	0.00106	CcSEcCtD
Nimodipine—Dizziness—Epirubicin—stomach cancer	0.000111	0.00105	CcSEcCtD
Nimodipine—Pruritus—Doxorubicin—stomach cancer	0.00011	0.00104	CcSEcCtD
Nimodipine—Vomiting—Epirubicin—stomach cancer	0.000107	0.00101	CcSEcCtD
Nimodipine—Nausea—Methotrexate—stomach cancer	0.000106	0.00101	CcSEcCtD
Nimodipine—Diarrhoea—Doxorubicin—stomach cancer	0.000106	0.00101	CcSEcCtD
Nimodipine—Rash—Epirubicin—stomach cancer	0.000106	0.001	CcSEcCtD
Nimodipine—Dermatitis—Epirubicin—stomach cancer	0.000106	0.001	CcSEcCtD
Nimodipine—Headache—Epirubicin—stomach cancer	0.000105	0.000996	CcSEcCtD
Nimodipine—Dizziness—Doxorubicin—stomach cancer	0.000103	0.000973	CcSEcCtD
Nimodipine—Nausea—Epirubicin—stomach cancer	9.96e-05	0.000944	CcSEcCtD
Nimodipine—Vomiting—Doxorubicin—stomach cancer	9.86e-05	0.000935	CcSEcCtD
Nimodipine—Rash—Doxorubicin—stomach cancer	9.78e-05	0.000928	CcSEcCtD
Nimodipine—Dermatitis—Doxorubicin—stomach cancer	9.77e-05	0.000927	CcSEcCtD
Nimodipine—Headache—Doxorubicin—stomach cancer	9.72e-05	0.000922	CcSEcCtD
Nimodipine—Nausea—Doxorubicin—stomach cancer	9.21e-05	0.000874	CcSEcCtD
Nimodipine—CACNB2—Axon guidance—VEGFA—stomach cancer	2.82e-05	0.000165	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	2.8e-05	0.000163	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—KRAS—stomach cancer	2.8e-05	0.000163	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP2A6—stomach cancer	2.8e-05	0.000163	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—KRAS—stomach cancer	2.8e-05	0.000163	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ERCC2—stomach cancer	2.77e-05	0.000162	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NDUFV1—stomach cancer	2.75e-05	0.000161	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NDUFS1—stomach cancer	2.75e-05	0.000161	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TNF—stomach cancer	2.75e-05	0.00016	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—KRAS—stomach cancer	2.72e-05	0.000159	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKR1C3—stomach cancer	2.72e-05	0.000159	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALOX5—stomach cancer	2.71e-05	0.000158	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—PPARG—stomach cancer	2.7e-05	0.000158	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	2.69e-05	0.000157	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTT1—stomach cancer	2.68e-05	0.000156	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—RHOA—stomach cancer	2.67e-05	0.000156	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—VEGFA—stomach cancer	2.67e-05	0.000156	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MAPK3—stomach cancer	2.67e-05	0.000156	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—DPYD—stomach cancer	2.66e-05	0.000155	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ENO1—stomach cancer	2.65e-05	0.000155	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP2A6—stomach cancer	2.65e-05	0.000155	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MMP9—stomach cancer	2.61e-05	0.000152	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MMP9—stomach cancer	2.61e-05	0.000152	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—ERBB2—stomach cancer	2.61e-05	0.000152	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—MTHFR—stomach cancer	2.61e-05	0.000152	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—IL6R—stomach cancer	2.6e-05	0.000152	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKR1C3—stomach cancer	2.58e-05	0.00015	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MAPK1—stomach cancer	2.54e-05	0.000148	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—EGFR—stomach cancer	2.54e-05	0.000148	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MAPK3—stomach cancer	2.53e-05	0.000147	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ENO1—stomach cancer	2.51e-05	0.000146	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP2—stomach cancer	2.48e-05	0.000145	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—ERBB2—stomach cancer	2.47e-05	0.000144	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PGLS—stomach cancer	2.45e-05	0.000143	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—BLVRB—stomach cancer	2.45e-05	0.000143	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—PPARG—stomach cancer	2.44e-05	0.000142	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CAV1—stomach cancer	2.41e-05	0.00014	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MAPK1—stomach cancer	2.4e-05	0.00014	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—EGFR—stomach cancer	2.4e-05	0.00014	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—APOA1—stomach cancer	2.4e-05	0.00014	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—KRAS—stomach cancer	2.4e-05	0.00014	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—HRAS—stomach cancer	2.38e-05	0.000139	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—HRAS—stomach cancer	2.38e-05	0.000139	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTT1—stomach cancer	2.35e-05	0.000137	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CD44—stomach cancer	2.35e-05	0.000137	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—RHOA—stomach cancer	2.35e-05	0.000137	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VEGFA—stomach cancer	2.35e-05	0.000137	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VEGFA—stomach cancer	2.35e-05	0.000137	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPAP2A—stomach cancer	2.34e-05	0.000137	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP2A6—stomach cancer	2.33e-05	0.000136	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—STAT3—stomach cancer	2.32e-05	0.000136	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—HRAS—stomach cancer	2.32e-05	0.000135	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—HRAS—stomach cancer	2.3e-05	0.000134	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—IL6—stomach cancer	2.28e-05	0.000133	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—IL6—stomach cancer	2.28e-05	0.000133	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—KRAS—stomach cancer	2.27e-05	0.000132	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKR1C3—stomach cancer	2.26e-05	0.000132	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MMP9—stomach cancer	2.24e-05	0.000131	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CD44—stomach cancer	2.23e-05	0.00013	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MAPK3—stomach cancer	2.22e-05	0.00013	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MAPK3—stomach cancer	2.22e-05	0.000129	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—IL6—stomach cancer	2.22e-05	0.000129	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ENO1—stomach cancer	2.21e-05	0.000129	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—SERPINE1—stomach cancer	2.2e-05	0.000128	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—ERBB2—stomach cancer	2.17e-05	0.000127	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MMP9—stomach cancer	2.12e-05	0.000124	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PPARG—stomach cancer	2.11e-05	0.000123	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MAPK1—stomach cancer	2.11e-05	0.000123	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—EGFR—stomach cancer	2.11e-05	0.000123	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MAPK1—stomach cancer	2.11e-05	0.000123	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—EGFR—stomach cancer	2.11e-05	0.000123	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CA1—stomach cancer	2.09e-05	0.000122	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NDUFA2—stomach cancer	2.09e-05	0.000122	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CKB—stomach cancer	2.09e-05	0.000122	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—FBP1—stomach cancer	2.09e-05	0.000122	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—HRAS—stomach cancer	2.04e-05	0.000119	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VEGFA—stomach cancer	2.01e-05	0.000117	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TNF—stomach cancer	2.01e-05	0.000117	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PPP2R1A—stomach cancer	2e-05	0.000117	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—KRAS—stomach cancer	2e-05	0.000116	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—KRAS—stomach cancer	2e-05	0.000116	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—STAT3—stomach cancer	1.99e-05	0.000116	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTP1—stomach cancer	1.96e-05	0.000115	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTP1—stomach cancer	1.96e-05	0.000114	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PLIN2—stomach cancer	1.96e-05	0.000114	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CD44—stomach cancer	1.96e-05	0.000114	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—IL6—stomach cancer	1.95e-05	0.000114	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	1.94e-05	0.000113	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—HMOX1—stomach cancer	1.93e-05	0.000113	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—HRAS—stomach cancer	1.93e-05	0.000113	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CA2—stomach cancer	1.91e-05	0.000111	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—stomach cancer	1.91e-05	0.000111	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MAPK3—stomach cancer	1.9e-05	0.000111	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ALB—stomach cancer	1.9e-05	0.000111	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PPP2R1A—stomach cancer	1.89e-05	0.00011	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—STAT3—stomach cancer	1.89e-05	0.00011	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP9—stomach cancer	1.86e-05	0.000109	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NT5E—stomach cancer	1.86e-05	0.000108	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PGAM1—stomach cancer	1.86e-05	0.000108	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTP1—stomach cancer	1.86e-05	0.000108	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—IL6—stomach cancer	1.85e-05	0.000108	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—HMOX1—stomach cancer	1.83e-05	0.000107	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TYMS—stomach cancer	1.82e-05	0.000106	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—NOS3—stomach cancer	1.82e-05	0.000106	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MAPK1—stomach cancer	1.81e-05	0.000106	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EGFR—stomach cancer	1.81e-05	0.000106	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTM1—stomach cancer	1.8e-05	0.000105	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MAPK3—stomach cancer	1.8e-05	0.000105	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTM1—stomach cancer	1.8e-05	0.000105	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	1.78e-05	0.000104	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PLCE1—stomach cancer	1.77e-05	0.000103	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALDH7A1—stomach cancer	1.77e-05	0.000103	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TYMS—stomach cancer	1.73e-05	0.000101	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TNF—stomach cancer	1.72e-05	0.000101	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MAPK1—stomach cancer	1.72e-05	0.0001	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EGFR—stomach cancer	1.72e-05	0.0001	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KRAS—stomach cancer	1.71e-05	9.98e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTM1—stomach cancer	1.71e-05	9.96e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—UMPS—stomach cancer	1.7e-05	9.92e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—HRAS—stomach cancer	1.7e-05	9.89e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—HRAS—stomach cancer	1.7e-05	9.89e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ERCC2—stomach cancer	1.69e-05	9.89e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ACAD8—stomach cancer	1.69e-05	9.85e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—stomach cancer	1.67e-05	9.77e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PPP2R1A—stomach cancer	1.66e-05	9.71e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTGS2—stomach cancer	1.66e-05	9.7e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—STAT3—stomach cancer	1.66e-05	9.67e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TNF—stomach cancer	1.63e-05	9.53e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTP1—stomach cancer	1.63e-05	9.52e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—IL6—stomach cancer	1.62e-05	9.47e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—IL6—stomach cancer	1.62e-05	9.47e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KRAS—stomach cancer	1.62e-05	9.45e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—HMOX1—stomach cancer	1.61e-05	9.39e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ERCC2—stomach cancer	1.6e-05	9.36e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—MTHFR—stomach cancer	1.59e-05	9.29e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MAPK3—stomach cancer	1.58e-05	9.24e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PDHA1—stomach cancer	1.58e-05	9.22e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ECHS1—stomach cancer	1.58e-05	9.22e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TYMS—stomach cancer	1.52e-05	8.85e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—MTHFR—stomach cancer	1.51e-05	8.8e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MAPK1—stomach cancer	1.51e-05	8.79e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EGFR—stomach cancer	1.51e-05	8.79e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GMPR2—stomach cancer	1.51e-05	8.78e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTM1—stomach cancer	1.5e-05	8.75e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TYMP—stomach cancer	1.49e-05	8.67e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—FADS1—stomach cancer	1.49e-05	8.67e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CAV1—stomach cancer	1.47e-05	8.57e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—APOA1—stomach cancer	1.47e-05	8.55e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—HRAS—stomach cancer	1.45e-05	8.48e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TNF—stomach cancer	1.44e-05	8.37e-05	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MAPK3—stomach cancer	1.43e-05	8.35e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KRAS—stomach cancer	1.42e-05	8.3e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ERCC2—stomach cancer	1.41e-05	8.23e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—IL6—stomach cancer	1.39e-05	8.12e-05	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—stomach cancer	1.39e-05	8.12e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SREBF2—stomach cancer	1.39e-05	8.12e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CAV1—stomach cancer	1.39e-05	8.12e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—APOA1—stomach cancer	1.39e-05	8.1e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—HRAS—stomach cancer	1.38e-05	8.03e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SUCLG1—stomach cancer	1.38e-05	8.03e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—IDH3B—stomach cancer	1.38e-05	8.03e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—RORA—stomach cancer	1.38e-05	8.02e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—MTHFR—stomach cancer	1.33e-05	7.73e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—IL6—stomach cancer	1.32e-05	7.69e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PPARG—stomach cancer	1.29e-05	7.53e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALDOB—stomach cancer	1.29e-05	7.52e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.28e-05	7.46e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.28e-05	7.46e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PPARG—stomach cancer	1.22e-05	7.14e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CAV1—stomach cancer	1.22e-05	7.13e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—APOA1—stomach cancer	1.22e-05	7.12e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—HRAS—stomach cancer	1.21e-05	7.06e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALOX5—stomach cancer	1.2e-05	6.99e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—DPYD—stomach cancer	1.18e-05	6.88e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ALB—stomach cancer	1.16e-05	6.78e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—IL6—stomach cancer	1.16e-05	6.76e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PGLS—stomach cancer	1.14e-05	6.65e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—BLVRB—stomach cancer	1.14e-05	6.65e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NOS3—stomach cancer	1.11e-05	6.48e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ALB—stomach cancer	1.1e-05	6.42e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.09e-05	6.35e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PPARG—stomach cancer	1.07e-05	6.27e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NOS3—stomach cancer	1.05e-05	6.14e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTT1—stomach cancer	1.04e-05	6.08e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP2A6—stomach cancer	1.03e-05	6.01e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CA—stomach cancer	1.02e-05	5.97e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS2—stomach cancer	1.02e-05	5.93e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKR1C3—stomach cancer	1e-05	5.85e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ENO1—stomach cancer	9.77e-06	5.7e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CKB—stomach cancer	9.7e-06	5.66e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CA1—stomach cancer	9.7e-06	5.66e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NDUFA2—stomach cancer	9.7e-06	5.66e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—FBP1—stomach cancer	9.7e-06	5.66e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALB—stomach cancer	9.67e-06	5.64e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS2—stomach cancer	9.62e-06	5.61e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NOS3—stomach cancer	9.25e-06	5.39e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PLIN2—stomach cancer	9.12e-06	5.32e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CA2—stomach cancer	8.87e-06	5.17e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CD44—stomach cancer	8.66e-06	5.05e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NT5E—stomach cancer	8.64e-06	5.04e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PGAM1—stomach cancer	8.64e-06	5.04e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS2—stomach cancer	8.46e-06	4.93e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALDH7A1—stomach cancer	8.25e-06	4.81e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PLCE1—stomach cancer	8.25e-06	4.81e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—UMPS—stomach cancer	7.91e-06	4.61e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPP2R1A—stomach cancer	7.37e-06	4.3e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PDHA1—stomach cancer	7.35e-06	4.29e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ECHS1—stomach cancer	7.35e-06	4.29e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTP1—stomach cancer	7.22e-06	4.21e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HMOX1—stomach cancer	7.13e-06	4.16e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TYMP—stomach cancer	6.91e-06	4.03e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—FADS1—stomach cancer	6.91e-06	4.03e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TYMS—stomach cancer	6.72e-06	3.92e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTM1—stomach cancer	6.64e-06	3.87e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SREBF2—stomach cancer	6.47e-06	3.77e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—RORA—stomach cancer	6.39e-06	3.73e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CA—stomach cancer	6.25e-06	3.65e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ERCC2—stomach cancer	6.24e-06	3.64e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALDOB—stomach cancer	5.99e-06	3.49e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CA—stomach cancer	5.92e-06	3.45e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTHFR—stomach cancer	5.87e-06	3.42e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALOX5—stomach cancer	5.57e-06	3.25e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—DPYD—stomach cancer	5.48e-06	3.2e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CAV1—stomach cancer	5.41e-06	3.16e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—APOA1—stomach cancer	5.4e-06	3.15e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CA—stomach cancer	5.2e-06	3.03e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTT1—stomach cancer	4.85e-06	2.83e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP2A6—stomach cancer	4.79e-06	2.79e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPARG—stomach cancer	4.76e-06	2.78e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKR1C3—stomach cancer	4.66e-06	2.72e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ENO1—stomach cancer	4.54e-06	2.65e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALB—stomach cancer	4.28e-06	2.5e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NOS3—stomach cancer	4.09e-06	2.39e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CD44—stomach cancer	4.03e-06	2.35e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS2—stomach cancer	3.74e-06	2.18e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.42e-06	2e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTP1—stomach cancer	3.36e-06	1.96e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HMOX1—stomach cancer	3.31e-06	1.93e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TYMS—stomach cancer	3.12e-06	1.82e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTM1—stomach cancer	3.09e-06	1.8e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ERCC2—stomach cancer	2.9e-06	1.69e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTHFR—stomach cancer	2.73e-06	1.59e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CAV1—stomach cancer	2.52e-06	1.47e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—APOA1—stomach cancer	2.51e-06	1.46e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CA—stomach cancer	2.3e-06	1.34e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPARG—stomach cancer	2.21e-06	1.29e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALB—stomach cancer	1.99e-06	1.16e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NOS3—stomach cancer	1.9e-06	1.11e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS2—stomach cancer	1.74e-06	1.01e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.07e-06	6.24e-06	CbGpPWpGaD
